
Five additional states have officially joined the Federal Trade Commission (FTC) in a sprawling lawsuit against telehealth provider Hims & Hers Health, alleging the company engaged in deceptive and unlawful privacy practices.
The amended complaint, filed Tuesday in the U.S. District Court for the Northern District of California, adds Arizona,Florida, Nebraska, Ohio, and Wisconsin as co-plaintiffs. They join the state of Utah and Los Angeles County, which originally signed onto the regulatory action when the FTC first initiated it in July.
Regulators contend that Hims & Hers—one of the largest telehealth platforms offering direct-to-consumer treatments for weight loss, erectile dysfunction, and mental health—systematically passed sensitive health data to third-party advertising networks, including Meta Platforms and Snap. According to the filing, the company shared this personal medical information despite explicitly stating to users that its services strictly safeguarded patient privacy.
Beyond the privacy breaches, the expanded lawsuit accuses the company of employing deceptive financial practices.Regulators claim Hims & Hers charged users for prescription medications almost immediately after they completed online intake forms—before they even consulted with a healthcare provider or established a legitimate treatment plan. The complaint also alleges the platform intentionally made it difficult for patients to cancel their ongoing subscriptions.
Hims & Hers has fiercely pushed back against the regulatory scrutiny. A company spokesperson stated on Tuesday that the firm will “vigorously defend” itself against the newly added state claims, describing the government’s underlying allegations as “flawed” and “baseless.” Last month, the telehealth company formally asked a federal judge to dismiss the case entirely; a hearing on that motion is scheduled for January 7, 2027.
The mounting legal pressure arrives at a complicated moment for the company’s financial outlook. Following the news of the expanded lawsuit and a recent cut to its full-year core profit forecast, Hims & Hers shares plunged over 16% in Tuesday trading to roughly $19.13.

